Founded by entrepreneurs disguised as scientists at the University of Kansas, Likarda is an exciting new biotech company bringing to market disruptive technologies that improve healthcare outcomes and lower costs for pets and people alike. As the leading regenerative medicine company for companion animals, Likarda has discovered — and is commercializing — a new dimension for managing diabetes in dogs and cats.
Likarda utilizes a proprietary cell culture system to create three-dimensional cell clusters, or miniaturized organs, having applications in markets from drug discovery and development to cell-based transplantation and regenerative medicine. Likarda combines visionary leadership, science that is just as artistic as academic and a compelling urge to do what’s right. What results is a new dimension in healing pets and people.
But that is just the beginning. Because Likarda’s technologies span across animal and human platforms, this next generation company is already becoming a pioneer for future generations of translational medicine.
News & Media
Likarda becomes profitable through services arm
Animal Pharm – September 11, 2014
Pets leave lasting contribution through Pet Organ Donation Network
PBS NewsHour – August 7, 2014
Kansas bioscience firm uses pet organ donations for research
Kansas City Business Journal – July 30, 2014
Kansas universities’ research having increasing economic impact
Topeka Capital-Journal – December 21, 2013
Likarda dog diabetes treatment set to become reality
Animal Pharm Journal – October 16, 2013
Video: Likarda Featured on KCPT’s The Local Show
September 19, 2013